Antibiotic therapy for XXXX @entity2259 .

@entity1 @entity5125 @entity2886 @entity6101 @entity3397 @entity3400 @entity869 @entity2259 @entity4028 @entity288
@entity5125 has been recognized as an important pathogen in immunocompromised @entity1 , but it has been rarely reported in Taiwan. We reviewed 13 cases of @entity5125 @entity2259 at National Taiwan University Hospital over a 12-year period. All of the @entity1 had underlying diseases. Fever was the most common presenting symptom, and neurologic signs were found in 6 @entity1 . Most of the @entity1 received @entity3397 , @entity869 or @entity3400 with an @entity4028 . @entity288 were used in 9 of 13 @entity1 . The overall mortality directly due to @entity5125 @entity2259 was 31%. However, @entity1 treated with @entity2886 or @entity6101 had higher mortality than those treated with @entity3397 , @entity869 or @entity3400 (p = 0.05). Given the increasing number of immunosuppressed @entity1 in Taiwan, it is likely that more cases will be encountered. Physicians in Taiwan should be aware of @entity5125 @entity2259 and its treatment.
